Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
251
-
Total 13F shares, excl. options
-
69M
-
Shares change
-
+1.9M
-
Total reported value, excl. options
-
$5.82B
-
Value change
-
+$164M
-
Put/Call ratio
-
0.97
-
Number of buys
-
123
-
Number of sells
-
-104
-
Price
-
$84.27
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q4 2019
312 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q4 2019.
NovoCure Ltd - Common Stock (NVCR) has 251 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69M shares
of 112M outstanding shares and own 61.65% of the company stock.
Largest 10 shareholders include FMR LLC (12.2M shares), BAILLIE GIFFORD & CO (8.01M shares), VANGUARD GROUP INC (7.25M shares), BlackRock Inc. (5.73M shares), Capital World Investors (5.04M shares), RENAISSANCE TECHNOLOGIES LLC (2.24M shares), STATE STREET CORP (1.67M shares), Capital International Investors (1.38M shares), MORGAN STANLEY (1.35M shares), and Darsana Capital Partners LP (1.35M shares).
This table shows the top 251 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.